ACM
IART icon

Atlanta Capital Management’s Integra LifeSciences IART Stock Holding History

Atlanta Capital Management’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$38.2M Sell
901,115
-19,238
-2% -$986K 0.17% 118
2022
Q2 		$49.7M Sell
920,353
-35,644
-4% -$2.14M 0.21% 113
2022
Q1 		$61.4M Sell
955,997
-4,421
-0.5% -$291K 0.23% 110
2021
Q4 		$64.3M Buy
960,418
+19,271
+2% +$1.3M 0.22% 113
2021
Q3 		$64.5M Sell
941,147
-38,423
-4% -$2.71M 0.23% 109
2021
Q2 		$66.8M Sell
979,570
-35,880
-4% -$2.54M 0.23% 109
2021
Q1 		$70.2M Sell
1,015,450
-92,766
-8% -$6.28M 0.25% 102
2020
Q4 		$71.9M Sell
1,108,216
-60,591
-5% -$3.26M 0.26% 99
2020
Q3 		$55.2M Buy
1,168,807
+112,747
+11% +$5.36M 0.23% 111
2020
Q2 		$49.6M Buy
1,056,060
+172,153
+19% +$8.46M 0.21% 114
2020
Q1 		$39.5M Buy
883,907
+190,901
+28% +$10M 0.21% 111
2019
Q4 		$40.4M Buy
693,006
+11,594
+2% +$690K 0.17% 115
2019
Q3 		$40.9M Sell
681,412
-4,583
-0.7% -$273K 0.18% 107
2019
Q2 		$38.3M Sell
685,995
-28,613
-4% -$1.47M 0.17% 108
2019
Q1 		$39.8M Sell
714,608
-13,547
-2% -$690K 0.19% 106
2018
Q4 		$32.8M Buy
728,155
+84,944
+13% +$4.66M 0.18% 109
2018
Q3 		$42.4M Buy
643,211
+4,168
+0.7% +$259K 0.2% 97
2018
Q2 		$41.2M Sell
639,043
-17,792
-3% -$1.1M 0.21% 88
2018
Q1 		$36.3M Sell
656,835
-7,920
-1% -$415K 0.19% 99
2017
Q4 		$31.8M Sell
664,755
-24,010
-3% -$1.18M 0.17% 106
2017
Q3 		$34.8M Sell
688,765
-8,629
-1% -$443K 0.2% 102
2017
Q2 		$38M Sell
697,394
-13,297
-2% -$635K 0.22% 92
2017
Q1 		$29.9M Buy
710,691
+37,773
+6% +$1.61M 0.18% 114
2016
Q4 		$28.9M Buy
672,918
+71,094
+12% +$2.89M 0.18% 116
2016
Q3 		$24.8M Buy
+601,824
New +$25.2M 0.16% 124

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
EVM
Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Atlanta Capital Management's IART Position: Q3 2022 in Review

Atlanta Capital Management reduced its Integra LifeSciences (IART) stake by 2.1% in Q3 2022, selling an estimated $986K and leaving 901,115 shares worth $38.2M. The position accounts for 0.17% of the portfolio, ranked #118.

Atlanta Capital Management first reported a position in IART in Q3 2016 and has held it in 25 quarters since. The position peaked at $71.9M in Q4 2020. 282 funds tracked by Wall St. Rank hold IART as of Q3 2022.

  • Atlanta Capital Management held 901,115 shares of Integra LifeSciences worth $38.2M as of Q3 2022.
  • Atlanta Capital Management sold 19,238 Integra LifeSciences shares in Q3 2022, an estimated $986K.
  • Integra LifeSciences made up 0.17% of Atlanta Capital Management's portfolio in Q3 2022, its #118 holding.
  • Atlanta Capital Management first reported a position in Integra LifeSciences in Q3 2016 and has held it in 25 quarters since.
  • Atlanta Capital Management's Integra LifeSciences position peaked at $71.9M in Q4 2020.
  • 282 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2022.

Based on Atlanta Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.